Searched for
IGI EBITDA MARGIN
Motilal Oswal sees 28% upside in Glenmark Pharma, hails $700 mln cancer drug deal as ‘new era’ for innovation playGlenmark Pharma shares: The brokerage noted that the agreement—executed through Glenmark’s subsidiary, Ichnos Glenmark Innovation (IGI)—“va...11 Jul, 2025, 02.16 PM IST- Reduce Glenmark Pharmaceuticals, target price Rs 1,265: ICICI SecuritiesICICI Securities maintains a Reduce call on Glenmark Pharmaceuticals with a target price of Rs 1,265. The current market price is Rs 1365.9...20 Feb, 2025, 09.51 AM IST
- Glenmark Pharma shares in focus as company swings back to profit in Q3Glenmark Pharmaceuticals reported a net profit of Rs 348 crore for Q3FY25, a significant turnaround from a Rs 351 crore loss in the previou...17 Feb, 2025, 08.14 AM IST
- Glenmark Pharmaceuticals Q3 Results: PAT at Rs 348 crore versus YoY loss, revenue up 35%Glenmark Pharmaceuticals Q3 Results: Glenmark Pharmaceuticals posted a net profit of ₹348 crore in Q3 FY25, reversing a ₹351 crore loss YoY...14 Feb, 2025, 08.08 PM IST
- IGI to use IPO proceeds of India entity to make acquisitions: IGI managementIGI, a leading gemstone and diamond certification body, is pursuing an IPO in India to consolidate its global operations and capitalize on ...16 Dec, 2024, 03.45 PM IST
- IGI offers long-term play for investors keen on niche bizThe company's revenues grew at a CAGR of 32.3% from ₹365 crore in FY22 to ₹638 crore in FY24. Net profit rose at a CAGR of 37.6% to ₹325 cr...13 Dec, 2024, 06.00 AM IST
Load More
